Who Should be Brought Into the Conversation Around Women’s Health?
During a panel discussion at HLTH, executives discussed why employers and men should be more engaged in women's health.
Top sex doc on FDA approval of Addyi, women’s libido pill: ‘A nuclear bomb has exploded in women’s sexual health’
Dr. Irwin Goldstein, president of the Institute for Sexual Medicine, extolled the approval of Addyi, the first-ever drug approved to treat women's sexual dysfunction. He says it'll open the door for further conversation and research about women's health.
presented by
MedCity News Pivot Podcast: How Emergency Departments Are Using Real-Time Data to Improve Outcomes
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
Many people think women deserve their version of Viagra, and it looks like they might get it
Pending FDA approval, women could soon have their own drug designed to increase sexual desire.
Pharma reviving Boehringer’s female sexual dysfunction drug gets $17.6M
Using a compound that Boehringer Ingelheim abandoned two years ago, Sprout Pharmaceuticals is taking a $20 million step toward developing a drug therapy specifically for hypoactive sexual desire disorder (HSDD) in women. The Raleigh, North Carolina-based drug company has raised $17.6 million of a $20 million round of financing, according to a recent U.S. Securities […]
Sprout Pharma takes root raising $5M for sexual dysfunction drug
Could a female Viagra be developed? Sprout Pharmaceuticals wants to find out if it can make a so-called pink Viagra and it’s picking up where German pharmaceutical company Boehringer Ingelheim left off. Sprout acquired flibanserin, a compound that Boehringer pursued as a drug to treat hypoactive sexual desire disorder, or HSDD — essentially, diminished sexual […]